Xuejun Xia
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery 10
- Advanced Drug Delivery Systems 8
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 10
- Pharmacology top 10%
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 3
-
- Nanoplatforms for cancer theranostics 6
-
- Cancer Treatment and Pharmacology 4
-
- Medicinal Plants and Neuroprotection 2
In The Last Decade
Xuejun Xia
40 papers receiving 911 citations
Peers
Comparison fields: 5 of 106
- Pharmaceutical Science 222
- Biomaterials 258
- Pharmacology 58
- Molecular Medicine 32
- Molecular Biology 386
Countries citing papers authored by Xuejun Xia
This map shows the geographic impact of Xuejun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Xia more than expected).
Fields of papers citing papers by Xuejun Xia
This network shows the impact of papers produced by Xuejun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Xia. The network helps show where Xuejun Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuejun Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 14 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 25 | |
| 9 | 2019 | 66 | |
| 10 | 2018 | 37 | |
| 11 | 2017 | 13 | |
| 12 | 2017 | 21 | |
| 13 | 2016 | 45 | |
| 14 | 2016 | 33 | |
| 15 | 2016 | 25 | |
| 16 | 2016 | 23 | |
| 17 | 2016 | 88 | |
| 18 | 2015 | 34 | |
| 19 | 2015 | 3 | |
| 20 | 2015 | 61 |
About Xuejun Xia
Xuejun Xia is a scholar working on Pharmaceutical Science, Biomaterials and Pharmacology, having authored 41 papers that have together received 926 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (10 papers), Advancements in Transdermal Drug Delivery (10 papers), Advanced Drug Delivery Systems (8 papers), Nanoplatforms for cancer theranostics (6 papers), Cancer Treatment and Pharmacology (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Medicinal Plants and Neuroprotection (2 papers). The work is most often cited by research in Pharmaceutical Science (222 citations), Biomaterials (258 citations) and Pharmacology (58 citations). Xuejun Xia has collaborated with scholars based in China and Czechia. Frequent co-authors include Yuling Liu, Wujun Dong, Yanfang Yang, Jun Ye, Cuiping Zhou, Yuling Liu, Hongliang Wang, Liyao Liu, Panpan Ma and Lin Li. Their work appears in journals such as Molecules, International Journal of Nanomedicine, Pharmaceutics, Journal of Controlled Release and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.